SCHEMBL472919

SCHEMBL472919

O=C1C=CN=C(O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3291489 0.98
SCHEMBL2406914 0.70
SCHEMBL10667405 0.70
SCHEMBL30982574 0.69 GSK3A (0.35)
Hydrochloric Acid SCHEMBL10721534 0.67 GSK3A (0.33)
SCHEMBL5397009 0.67
SCHEMBL30983029 0.65
SCHEMBL3666439 0.65 KDM4E (0.41)
SCHEMBL31055644 0.65 GSK3A (0.36)
SCHEMBL31693453 0.64 GSK3A (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114716366-B 3-hydroxypyridin-4-one derivatives and application thereof in inhibiting iron death of renal cells 浙江大学 2023-12-26 CN claimed
CN-1473153-A Hetero-anellated ortho-aminophenols 克莱里安特财务(BVI)有限公司 2004-02-04 CN claimed
US-20240200049-A1 COMPOSITIONS AND METHODS OF USE THEREOF FOR MAKING POLYPEPTIDES WITH MANY INSTANCES OF NONSTANDARD AMINO ACIDS YALE UNIVERSITY 2024-06-20 US disclosed
CN-114832119-B Radioactive gel microsphere and preparation method and application thereof 苏州大学 2024-02-09 CN disclosed
US-11649446-B2 Compositions and methods of use thereof for making polypeptides with many instances of nonstandard amino acids YALE UNIVERSITY (US) 2023-05-16 US disclosed
CN-115960109-A Preparation and application of fused-ring SHP2 phosphatase inhibitor 药雅科技(上海)有限公司 2023-04-14 CN disclosed
WO-2022237676-A1 PREPARATION AND APPLICATION OF SHP2 PHOSPHATASE INHIBITOR 药雅科技(上海)有限公司 2022-11-17 WO disclosed
CN-115340561-A Preparation and application of SHP2 phosphatase fused ring inhibitor 药雅科技(上海)有限公司 2022-11-15 CN disclosed
CN-115340559-A Preparation and application of SHP2 phosphatase heterocyclic inhibitor 药雅科技(上海)有限公司 2022-11-15 CN disclosed
CN-114832119-A Radioactive gel microsphere and preparation method and application thereof 苏州大学 2022-08-02 CN disclosed
CN-114716366-A 3-hydroxypyridine-4-ketone derivatives and application thereof in inhibition of renal cell iron death 浙江大学 2022-07-08 CN disclosed
EP-0107458-B1 PHARMACEUTICAL COMPOSITIONS NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1987-07-29 EP disclosed
US-4650793-A NITROGEN-SUBSTITUTED NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1987-03-17 US disclosed
EP-0094149-B1 PHARMACEUTICAL COMPOSITIONS CONTAINING A COMPLEX OF IRON WITH N-SUBSTITUTED 3-HYDROXYPYRID-2-ONE OR -4-ONE DERIVATIVES NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1986-09-10 EP disclosed
US-4575502-A IRON DEFICIENCY ANEMIA NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1986-03-11 US disclosed
EP-0159917-A2 Pharmaceutical composition containing a hydroxypyrone-iron complex NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1985-10-30 EP disclosed
US-4550101-A Iron complexes of hydroxy pyridones useful for treating iron deficiency anemia NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1985-10-29 US disclosed
EP-0120670-A1 Iron III complexes of hydroxypyridones, and their pharmaceutical compositions NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1984-10-03 EP disclosed
EP-0107458-A1 Pharmaceutical compositions NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1984-05-02 EP disclosed
EP-0094149-A2 Pharmaceutical compositions containing a complex of iron with N-substituted 3-hydroxypyrid-2-one or -4-one derivatives NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1983-11-16 EP disclosed